LARVAL DEBRIDEMENT THERAPY PRODUCTS - BIOBAG 50/100/200/300/400
K-Number: K131221 · 2013-08-28
Advertisement
Device Summary
Frequently Asked Questions
What is the LARVAL DEBRIDEMENT THERAPY PRODUCTS - BIOBAG 50/100/200/300/400?
LARVAL DEBRIDEMENT THERAPY PRODUCTS - BIOBAG 50/100/200/300/400 is a medical device that received FDA 510(k) clearance on 2013-08-28. The listed applicant is Biomonde. The 510(k) number is K131221.
When did LARVAL DEBRIDEMENT THERAPY PRODUCTS - BIOBAG 50/100/200/300/400 receive FDA 510(k) clearance?
LARVAL DEBRIDEMENT THERAPY PRODUCTS - BIOBAG 50/100/200/300/400 received FDA 510(k) clearance on 2013-08-28, under 510(k) number K131221.
Who is the listed applicant for LARVAL DEBRIDEMENT THERAPY PRODUCTS - BIOBAG 50/100/200/300/400?
The FDA 510(k) record lists Biomonde as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for LARVAL DEBRIDEMENT THERAPY PRODUCTS - BIOBAG 50/100/200/300/400?
The FDA product code for LARVAL DEBRIDEMENT THERAPY PRODUCTS - BIOBAG 50/100/200/300/400 is NQK.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: NQK)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.
Advertisement